Medical Director/Sr Director, Clinical Research

$250k - $350k

Location
Cambridge, MA
Workplace
Hybrid
Employment
Full-time

About this role

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

 

Summary of Position:

The (Senior) Medical Director, reporting to the VP, Clinical Research, will be a member of the clinical research team, accountable for driving clinical development activities for assigned pipeline products. The successful candidate will be responsible for providing medical leadership for clinical development activities in alignment with corporate strategy. This position requires a highly motivated physician scientist with hands-on expertise in advancing product candidates to deliver life-changing medicines.

\nPosition Responsibilities:
  • Provide medical leadership for clinical development activities of assigned pipeline products, including leading efforts to define clinical development strategy and plan
  • Collaborate with other members of the development and research teams to contribute to building a collaborative culture and improving effectiveness of the development team
  • Serve as subject matter expert, leading efforts to provide scientifically robust evaluation of development strategy and plans, including robust literature review to perform disease area assessment, development landscape analysis, and development and regulatory pathway evaluation
  • Engage with external scientific and clinical trial experts, clinical and regulatory consultants, to develop scientifically robust clinical study design
  • Provide hands-on authoring of clinical and regulatory documents, including study concepts, protocols, investigator brochures, regulatory documents, publications, etc.
  • Serve as lead author in clinical responses to regulatory authorities, related to review of protocols, INDs, BLA/MAA/JNDA, and other regulatory filings
  • Provide medical leadership and input in cross-functional team activities, including business development activities, non-clinical development, quality assurance, clinical operations, biostatistics, regulatory affairs and drug safety
  • Responsible for medical oversight of clinical trials, including medical monitoring of studies, adverse event reporting, and patient safety for all clinical trials across a development program.
  • Provide medical and scientific leadership in data analysis and interpretation, maintaining integrity, scientific rigor, and transparency
  • Work within compliance to all applicable GCP/ ICH regulations
Candidate Requirements:
  • MD, MD/PhD, or equivalent, based in greater Boston
  • Ability to be present regularly in the Cambridge MA office
  • Strong critical thinking skills, with ability to synthesize complex information, and exceptional communication skills, both verbal and written
  • 5+ years of experience in the biopharmaceutical industry, with 3+ years of clinical development experience; neuromuscular or rare disease experience preferred but not required
  • Highly organized, outcome-oriented, self-motivated team player with strong interpersonal skills and effective conflict management skills
  • Experience in innovative clinical study design, analysis of clinical data, publications, and working knowledge of biostatistics and pharmacokinetics/pharmacodynamics
  • Understanding of the drug development process from pre-IND through BLA
  • Experience interacting with health authorities in the US and EU
  • In-depth knowledge of ICH-GCP and other application regulatory guidelines
  • Ability to travel domestically and internationally (~15%)
\n
$250,000 - $350,000 a year
\n

Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. 

Apply to Scholar Rock

Clera fills in Scholar Rock's application for you.

How it works

Open the role in Clera

Sign in, and this role opens on your Clera job board, ready to apply.

Clera fills in the application

Clera fills the form from your profile and resume, and asks what's missing.

Track it in Clera

Each application you send shows up in your Clera tracker, sorted by stage.

Want Clera to find roles for you?

Ask your AI about this role

It knows you. Clera gives it the role.

Does this role fit my profile?

First time? Connect Clera once, about a minute.
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

About Scholar Rock

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.

Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock on X.

For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/

For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/

Team size
51-200 employees people
Founded
2012
Industry
Biotechnology
Workplace
Hybrid
Locations
Cambridge, Massachusetts, United States